Trials / Completed
CompletedNCT03353038
A 3D Printed Assistive Technology Intervention
A 3D Printed Assistive Technology Intervention: A Phase I Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Florida International University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to understand the feasibility of using a 3D printer to create tailored assistive technology rehabilitation devices. Specifically, we are investigating if a tailored 3D printed pillbox is safe, acceptable, and effective compared to an off-the-shelf generic pillbox. In this study, approximately 20 people with chronic health conditions who use pillboxes will describe their satisfaction and medication adherence with their current pillbox using a series of surveys and interviews. Then they will partake in an interview about their pillbox, medications, and routines. Based on the interview, the research team will 3D print a new pillbox tailored to the participant's preferences, abilities, and medication regimen. Then the participant will use the pillbox for 2-8 weeks. At the end, the participant will answer the same questions describing their satisfaction and medication adherence with the new pillbox using a series of surveys and interviews. This research will reveal important knowledge about the potential of 3D printing in the clinic and effectiveness of customized assistive technology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3D printed pillbox | The research team interviewed the participant about their habits, routines, preferences, medications, and skills and abilities. Based on the interview, the research team designed and printed a customized 3D printed pillbox. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2017-11-24
- Last updated
- 2017-11-24
Source: ClinicalTrials.gov record NCT03353038. Inclusion in this directory is not an endorsement.